Next |
home / stock / fmi / fmi message board
Subject | By | Source | When |
---|---|---|---|
Roche acquires majority stake in FMI @$50/sh | PennyStock Alert | investorshub | 09/16/2019 1:04:06 PM |
Congrats to all long!!! | Cheetah SPEED | investorshub | 06/19/2018 1:14:34 PM |
$FMI buy 74.90 | stocktrademan | investorshub | 02/19/2018 10:34:46 PM |
$FMI PR on FDA/CMS approval of FoundationOne CDx: | DewDiligence | investorshub | 12/01/2017 6:35:27 PM |
Looks like serious competition for $FMI: #msg-136227022. | DewDiligence | investorshub | 11/15/2017 7:04:09 PM |
FMI 3Q17 results: | DewDiligence | investorshub | 11/01/2017 8:15:38 PM |
FMI -5%/AH on 2017 guidance: | DewDiligence | investorshub | 02/22/2017 11:59:54 PM |
NOTE TO SELF | Klonopin2mg2000 | investorshub | 08/03/2016 3:45:34 PM |
sorry Dew... | Klonopin2mg2000 | investorshub | 08/02/2016 10:37:44 PM |
and of course to become moderator, one must | Klonopin2mg2000 | investorshub | 08/02/2016 10:33:35 PM |
and my agenda is to hope for conversation | Klonopin2mg2000 | investorshub | 08/02/2016 10:32:43 PM |
100th post = Luck | Klonopin2mg2000 | investorshub | 08/02/2016 10:31:48 PM |
Glad I bought this stock a few months | Klonopin2mg2000 | investorshub | 08/02/2016 10:28:34 PM |
If they pull off this Liquid Biopsy announcement | udontlikeit | investorshub | 03/15/2016 12:55:26 PM |
$FMI -8% on tepid 2016 guidance: #msg-119748405. | DewDiligence | investorshub | 01/11/2016 4:41:01 PM |
FMI +7% on two items: #msg-119332549. | DewDiligence | investorshub | 12/22/2015 12:09:14 AM |
Actually not a bad price when looking at | expediter13 | investorshub | 08/16/2015 5:29:06 PM |
Ive been out of the stock since my | DewDiligence | investorshub | 08/08/2015 4:45:06 PM |
Dew, what's your opinion on $FMI at this level? | copper11 | investorshub | 08/08/2015 2:48:53 PM |
WOW... Buy buy buy... How does this fall | expediter13 | investorshub | 08/06/2015 4:13:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Foundation Medicine Inc. Company Name:
FMI Stock Symbol:
NASDAQ Market:
Foundation Medicine Inc. Website:
The global athletic footwear market was valued at US$ 82.56 Billion in 2022 and is expected to expand at a CAGR of 4.8% during the forecast period, ranging from 2023 to 2033
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the addition of three independent directors to it...